Johnson & Johnson has issued another recall. This one is for about 57,000 bottles of a widely used epilepsy pill, and is due to complaints of a chemical odor. Two lots of 100-milligram tablets of Topamax, sold between October 19th and December 28, 2010 are being recalled. The lot numbers are OKG110 and OLG222. J&J said fewer than 6,000 of the bottles are believed to still be on the market. J&J said that the pills were sold only in the U.S. and Puerto Rico.
The New Brunswick, N.J., company has now issued 22 product recalls, involving well over 300 million bottles of medicines, since September 2009. Many of the recalls involved widely used nonprescription drugs such as Motrin and Children’s Tylenol. The reasons have ranged from metal and other contaminants, to nauseating odors and packaging issues. Joint replacement systems so painful they required corrective surgery were also recalled, as were contact lenses that irritated eyes, along with potentially contaminated syringes full of the antipsychotic drug Invega.
Johnson & Johnson said it had received four consumer complaints of an odor believed to be a chemical called TBA, or tribromoanisole, a byproduct of a chemical preservative sometimes used on shipping pallets. J&J said “a very small number of patients have reported temporary gastrointestinal symptoms,” but TBA is not considered toxic. The same issue was linked to some of its previous recalls.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.